Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
HD-CAR-1 - Heidelberg University Hospital
Yescarta (axicabtagene ciloleucel) - Gilead
https://library.ehaweb.org/eha/2024/eha2024-congress/422392/anna.ossami.saidy.efficacy.and.toxicity.of.anti-cd19.car.t-cells.in.patients.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29176%2Amarker%3D5099%2Afeatured%3D18527
 
Anna Ossami Saidy; Christophe Peczynski; Eva Michel; Jacques-Emmanuel. Galimard; Hervé Finel; Ariane Boumendil; Michael Daskalakis; Urban Novak; David Beauvais; Juergen Finke; Peter Vandenberghe; Philipp Berning; Nicolaus KRÖGER; Ron Ram; Matthias Stelljes; Malte Von Bonin; Wolfgang Bethge; Andrea Kuhnl; Friedrich Stölzel; Bastian von Tresckow; Stephan Fuhrmann; Anna Sureda Balari; Peter Dreger; Norbert Schmitz; Bertram Glass
 
May 15, 2024
 
Next